Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP771476.RAksH5AF7htmziwi2s7SIOf7mnIeUTk64-LXnZWWlftD0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP771476.RAksH5AF7htmziwi2s7SIOf7mnIeUTk64-LXnZWWlftD0130_assertion type Assertion NP771476.RAksH5AF7htmziwi2s7SIOf7mnIeUTk64-LXnZWWlftD0130_head.
- NP771476.RAksH5AF7htmziwi2s7SIOf7mnIeUTk64-LXnZWWlftD0130_assertion description "[One hundred and sixty-two chemotherapy-na�ve patients with locally advanced/metastatic NSCLC who received front-line chemotherapy were included in this retrospective study and their clinical outcome data was analyzed according to EGFR and K-RAS mutation status of their tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP771476.RAksH5AF7htmziwi2s7SIOf7mnIeUTk64-LXnZWWlftD0130_provenance.
- NP771476.RAksH5AF7htmziwi2s7SIOf7mnIeUTk64-LXnZWWlftD0130_assertion evidence source_evidence_literature NP771476.RAksH5AF7htmziwi2s7SIOf7mnIeUTk64-LXnZWWlftD0130_provenance.
- NP771476.RAksH5AF7htmziwi2s7SIOf7mnIeUTk64-LXnZWWlftD0130_assertion SIO_000772 19854533 NP771476.RAksH5AF7htmziwi2s7SIOf7mnIeUTk64-LXnZWWlftD0130_provenance.
- NP771476.RAksH5AF7htmziwi2s7SIOf7mnIeUTk64-LXnZWWlftD0130_assertion wasDerivedFrom befree-2016 NP771476.RAksH5AF7htmziwi2s7SIOf7mnIeUTk64-LXnZWWlftD0130_provenance.
- NP771476.RAksH5AF7htmziwi2s7SIOf7mnIeUTk64-LXnZWWlftD0130_assertion wasGeneratedBy ECO_0000203 NP771476.RAksH5AF7htmziwi2s7SIOf7mnIeUTk64-LXnZWWlftD0130_provenance.